In conclusion, our data confirm the prognostic (or predictive) significance of ER mRNA and protein expression in high-risk early breast cancer and highlight the heterogeneous nature of ESR1 gene copy number aberrations with respect to regulatory and functional impact on the cancer cell. The gene discussed is ESR1; the disease is breast carcinoma.